Wada K, Yamada N, Hamamura T, Suzuki H, Nakano Y, Kuroda S
Department of Neuropsychiatry, Okayama University Medical School, Japan.
Psychiatry Clin Neurosci. 1999 Oct;53(5):557-62. doi: 10.1046/j.1440-1819.1999.00605.x.
Add-on polytherapy with antidepressant agents was reviewed in 42 inpatients with major depression diagnosed according to the ICD-10 criteria. Twenty-eight (67.7%) patients were treated with two or more antidepressants. The most frequent combination consisted of a tricyclic antidepressant and a non-tricyclic antidepressant. Nineteen (67.8%) patients of the polytherapy group were treated with a dosage equivalent to 150 mg/day of tricyclic antidepressant. Clinically, not every patient with major depression can tolerate the adverse side effects induced by an effective dose of a single tricyclic antidepressant. From this viewpoint, add-on polytherapy with antidepressants could be one of the treatment options, especially for such intolerant patients.